Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Michelle D. Jordan"'
Publikováno v:
Open Forum Infectious Diseases
Background Previous data at our facility indicated 37% of patients with Clostridium difficile infection (CDI) were receiving at least one laxative at the time of testing, suggesting the possibility of false-positive results. Nucleic acid amplificatio
Autor:
Jonathan Polak, Ahmed Abubaker, Dawd S. Siraj, Michelle D. Jordan, Dora Lebron, Nada Fadul, Muhammad Salman Ashraf, Michael Gooch, Paul P. Cook, Salma Mohamed
Publikováno v:
Open Forum Infectious Diseases. 3
Autor:
Michael Gooch, Paul P. Cook, Suzanne Hudson, Shemra Rizzo, Michelle D. Jordan, Xiangming Fang
Publikováno v:
The Journal of antimicrobial chemotherapy. 66(1)
OBJECTIVES we evaluated the effect of implementation of an electronic medical record (EMR) on the use of antimicrobial agents and on the rates of infections with Clostridium difficile and methicillin-resistant Staphylococcus aureus (MRSA). METHODS th
Autor:
Holly E. Balcer, Katherine Lusardi, John E. Emanuel, Radhika S. Polisetty, Michael L. Johnson, Michelle D. Jordan, Dhara N. Shah, Fay S. Chan, Kevin W. Garey, Krutina P. Garcia, April P. Dyer, Ashley M. Tyler, Geri Naymick, Nandita Kachru, Lanny Sieman
Publikováno v:
SpringerPlus
Purpose Fidaxomicin use in real-world clinical practice, especially for severe Clostridium difficile infection (CDI), is mainly based on single-center observational studies. The purpose of this pharmacoepidemiology study was to assess outcomes of pat